BIRCHVIEW CAPITAL, LP Holdings

BIRCHVIEW CAPITAL, LP is an investment fund managing more than 142.01M US dollars. The largest holdings include Bristol-Myers Squibb Company, Aziyo Biologics and Neurocrine Biosciences. In Q3 2022 the fund bought assets of total value of 6.37M US dollars and sold assets of total value of 2.07M US dollars.

$142.01M

portfolio value

+2.40%

quarter

-12.30%

1 year

-70.47%

3 years

-51.25%

5 years

BIRCHVIEW CAPITAL, LP portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2016	-30437000	1876000
Q2 2016	1341000	1553000
Q3 2016	2552000	4012000
Q4 2016	1040000	583000
Q1 2017	10430000	3757000
Q2 2017	7837000	3352000
Q3 2017	5674000	7876000
Q4 2017	2623000	34202000
Q1 2018	5628000	15560000
Q2 2018	4341000	9362000
Q3 2018	3233000	2892000
Q4 2018	-13296000	6002000
Q1 2019	4403000	538000
Q2 2019	3771000	2676000
Q3 2019	8586000	1798000
Q4 2019	57678000	2924000
Q1 2020	-12873000	5236000
Q2 2020	35996000	609000
Q3 2020	2780000	3976000
Q4 2020	31423000	7887000
Q1 2021	7732000	4939000
Q2 2021	7893000	1836000
Q3 2021	-3982000	2443000
Q4 2021	10415000	937000
Q1 2022	-21000	1824000
Q2 2022	7006000	3371000
Q3 2022	6365000	2069000

BIRCHVIEW CAPITAL, LP 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Drug Manufacturers—General Bristol-Myers Squibb Company Portfolio share: 36.43% Portfolio value: 51.73M Avg. open price: $47.39 Current price: $80.7 P/L: +70.28% Sold -3.49% shares Q2 2022	share	36.43%	51.73M	$47.39	$80.7	+70.28%	Sold -3.49% shares Q2 2022
Medical Devices Aziyo Biologics, Inc. Portfolio share: 7.19% Portfolio value: 10.21M Avg. open price: $6.99 Current price: $3.61 P/L: -48.45% Bought +0.01% shares Q2 2022	share	7.19%	10.21M	$6.99	$3.61	-48.45%	Bought +0.01% shares Q2 2022
Drug Manufacturers—Specialty & Generic Neurocrine Biosciences, Inc. Portfolio share: 6.37% Portfolio value: 9.05M Avg. open price: $80.8 Current price: $124 P/L: +53.46% Sold -4.48% shares Q2 2022	share	6.37%	9.05M	$80.8	$124	+53.46%	Sold -4.48% shares Q2 2022
Biotechnology Prothena Corporation plc Portfolio share: 5.08% Portfolio value: 7.21M Avg. open price: $36.72 Current price: $60.39 P/L: +64.46% Bought +15.99% shares Q3 2022	share	5.08%	7.21M	$36.72	$60.39	+64.46%	Bought +15.99% shares Q3 2022
Medical Instruments & Supplies QuidelOrtho Corporation Portfolio share: 3.09% Portfolio value: 4.38M Avg. open price: $117.57 Current price: $93.6 P/L: -20.39% Bought +2.72% shares Q2 2022	share	3.09%	4.38M	$117.57	$93.6	-20.39%	Bought +2.72% shares Q2 2022
Biotechnology ACADIA Pharmaceuticals Inc. Portfolio share: 2.87% Portfolio value: 4.08M Avg. open price: $40.6 Current price: $15.24 P/L: -62.47% Bought +25.08% shares Q2 2022	share	2.87%	4.08M	$40.6	$15.24	-62.47%	Bought +25.08% shares Q2 2022
Oil & Gas E&P Ovintiv Inc. Portfolio share: 2.73% Portfolio value: 3.87M Avg. open price: $54.07 Current price: $51.51 P/L: -4.73% Bought +146.20% shares Q2 2022	share	2.73%	3.87M	$54.07	$51.51	-4.73%	Bought +146.20% shares Q2 2022
Medical Devices Accelerate Diagnostics, Inc. Portfolio share: 2.41% Portfolio value: 3.42M Avg. open price: $12.76 Current price: $0.75 P/L: -94.12% Bought +0.87% shares Q3 2021	share	2.41%	3.42M	$12.76	$0.75	-94.12%	Bought +0.87% shares Q3 2021
Biotechnology United Therapeutics Corporation Portfolio share: 2.21% Portfolio value: 3.14M Avg. open price: $88.08 Current price: $273.72 P/L: +210.76% Sold -16.67% shares Q2 2022	share	2.21%	3.14M	$88.08	$273.72	+210.76%	Sold -16.67% shares Q2 2022
Diagnostics & Research Biodesix, Inc. Portfolio share: 2.12% Portfolio value: 3.01M Avg. open price: $2.43 Current price: $1.43 P/L: -41.17% Bought +30.84% shares Q3 2022	share	2.12%	3.01M	$2.43	$1.43	-41.17%	Bought +30.84% shares Q3 2022
Oil & Gas E&P Continental Resources, Inc. Portfolio share: 1.82% Portfolio value: 2.57M Avg. open price: N/A Current price: $74.27 P/L: N/A N/A Q2 2020	share	1.82%	2.57M	N/A	$74.27	N/A	N/A Q2 2020
Biotechnology Foghorn Therapeutics Inc. Portfolio share: 1.60% Portfolio value: 2.27M Avg. open price: N/A Current price: $6.73 P/L: N/A Sold -7.02% shares Q3 2022	share	1.60%	2.27M	N/A	$6.73	N/A	Sold -7.02% shares Q3 2022
Biotechnology Albireo Pharma, Inc. Portfolio share: 1.59% Portfolio value: 2.26M Avg. open price: $31.38 Current price: $22.7 P/L: -27.65% Bought +3.54% shares Q3 2022	share	1.59%	2.26M	$31.38	$22.7	-27.65%	Bought +3.54% shares Q3 2022
Biotechnology Biohaven Ltd. Portfolio share: 1.57% Portfolio value: 2.22M Avg. open price: $134.59 Current price: $16.32 P/L: -87.87% Sold -1.80% shares Q3 2022	share	1.57%	2.22M	$134.59	$16.32	-87.87%	Sold -1.80% shares Q3 2022
Drug Manufacturers—Specialty & Generic Harrow Health, Inc. Portfolio share: 1.53% Portfolio value: 2.17M Avg. open price: N/A Current price: $12.39 P/L: N/A N/A Q1 2019	share	1.53%	2.17M	N/A	$12.39	N/A	N/A Q1 2019
Medical Instruments & Supplies Masimo Corporation Portfolio share: 1.52% Portfolio value: 2.15M Avg. open price: $172.21 Current price: $142.55 P/L: -17.22% Bought +64.66% shares Q2 2022	share	1.52%	2.15M	$172.21	$142.55	-17.22%	Bought +64.66% shares Q2 2022
Health Information Services Phreesia, Inc. Portfolio share: 1.48% Portfolio value: 2.10M Avg. open price: $26.36 Current price: $28.04 P/L: +6.37% Bought +727.00% shares Q2 2022	share	1.48%	2.10M	$26.36	$28.04	+6.37%	Bought +727.00% shares Q2 2022
Biotechnology Gossamer Bio, Inc. Portfolio share: 1.34% Portfolio value: 1.90M Avg. open price: $11.27 Current price: $9.29 P/L: -17.61% Bought +23.24% shares Q2 2022	share	1.34%	1.90M	$11.27	$9.29	-17.61%	Bought +23.24% shares Q2 2022
Biotechnology Ventyx Biosciences, Inc. Portfolio share: 1.11% Portfolio value: 1.57M Avg. open price: $12.77 Current price: $28.09 P/L: +120.04% Bought +36.36% shares Q3 2022	share	1.11%	1.57M	$12.77	$28.09	+120.04%	Bought +36.36% shares Q3 2022
Biotechnology Karyopharm Therapeutics Inc. Portfolio share: 1.04% Portfolio value: 1.47M Avg. open price: $15.45 Current price: $5.23 P/L: -66.15% Bought +9.48% shares Q1 2022	share	1.04%	1.47M	$15.45	$5.23	-66.15%	Bought +9.48% shares Q1 2022
Biotechnology Corcept Therapeutics Incorporated Portfolio share: 0.90% Portfolio value: 1.28M Avg. open price: $10.96 Current price: $23.4 P/L: +113.50% Sold -33.77% shares Q2 2018	share	0.90%	1.28M	$10.96	$23.4	+113.50%	Sold -33.77% shares Q2 2018
Biotechnology Inhibrx, Inc. Portfolio share: 0.89% Portfolio value: 1.26M Avg. open price: $29.41 Current price: $29.18 P/L: -0.78% Bought +39.64% shares Q2 2022	share	0.89%	1.26M	$29.41	$29.18	-0.78%	Bought +39.64% shares Q2 2022
Biotechnology Cytokinetics, Incorporated Portfolio share: 0.85% Portfolio value: 1.21M Avg. open price: $19.79 Current price: $38.12 P/L: +92.62% Bought +150.00% shares Q3 2021	share	0.85%	1.21M	$19.79	$38.12	+92.62%	Bought +150.00% shares Q3 2021
Biotechnology AVEO Pharmaceuticals, Inc. Portfolio share: 0.81% Portfolio value: 1.15M Avg. open price: $6.5 Current price: $14.91 P/L: +129.32% Bought +250.00% shares Q4 2021	share	0.81%	1.15M	$6.5	$14.91	+129.32%	Bought +250.00% shares Q4 2021
Drug Manufacturers—Specialty & Generic Alkermes plc Portfolio share: 0.79% Portfolio value: 1.11M Avg. open price: $18.68 Current price: $25.51 P/L: +36.56% Bought +42.86% shares Q2 2021	share	0.79%	1.11M	$18.68	$25.51	+36.56%	Bought +42.86% shares Q2 2021
Medical Care Facilities DocGo Inc. Portfolio share: 0.77% Portfolio value: 1.09M Avg. open price: $9.04 Current price: $6.84 P/L: -24.34% Bought +1000.00% shares Q1 2022	share	0.77%	1.09M	$9.04	$6.84	-24.34%	Bought +1000.00% shares Q1 2022
Biotechnology ChemoCentryx, Inc. Portfolio share: 0.73% Portfolio value: 1.03M Avg. open price: $39.55 Current price: $51.99 P/L: +31.45% Sold -20.00% shares Q4 2021	share	0.73%	1.03M	$39.55	$51.99	+31.45%	Sold -20.00% shares Q4 2021
Oil & Gas Midstream Equitrans Midstream Corporation Portfolio share: 0.70% Portfolio value: 995K Avg. open price: N/A Current price: $8.05 P/L: N/A N/A Q2 2020	share	0.70%	995K	N/A	$8.05	N/A	N/A Q2 2020
Biotechnology 2seventy bio, Inc. Portfolio share: 0.61% Portfolio value: 871K Avg. open price: $18.82 Current price: $15.36 P/L: -18.40% Bought +74.27% shares Q2 2022	share	0.61%	871K	$18.82	$15.36	-18.40%	Bought +74.27% shares Q2 2022
Oil & Gas E&P Pioneer Natural Resources Company Portfolio share: 0.58% Portfolio value: 823K Avg. open price: $162.36 Current price: $230.37 P/L: +41.89% Bought +26.67% shares Q4 2018	share	0.58%	823K	$162.36	$230.37	+41.89%	Bought +26.67% shares Q4 2018
Biotechnology Apellis Pharmaceuticals, Inc. Portfolio share: 0.58% Portfolio value: 820K Avg. open price: $63.2 Current price: $49.41 P/L: -21.83% Bought +50.00% shares Q3 2021	share	0.58%	820K	$63.2	$49.41	-21.83%	Bought +50.00% shares Q3 2021
Medical Devices Inari Medical, Inc. Portfolio share: 0.51% Portfolio value: 726K Avg. open price: $91.22 Current price: $71.11 P/L: -22.05% Bought +25.00% shares Q2 2022	share	0.51%	726K	$91.22	$71.11	-22.05%	Bought +25.00% shares Q2 2022
Biotechnology ImmunoGen, Inc. Portfolio share: 0.50% Portfolio value: 717K Avg. open price: $3.7 Current price: $5.43 P/L: +46.82% Sold -21.05% shares Q2 2022	share	0.50%	717K	$3.7	$5.43	+46.82%	Sold -21.05% shares Q2 2022
Biotechnology Arvinas, Inc. Portfolio share: 0.47% Portfolio value: 667K Avg. open price: N/A Current price: $39.53 P/L: N/A Sold -50.00% shares Q1 2020	share	0.47%	667K	N/A	$39.53	N/A	Sold -50.00% shares Q1 2020
Biotechnology bluebird bio, Inc. Portfolio share: 0.44% Portfolio value: 620K Avg. open price: $20.23 Current price: $8.01 P/L: -60.41% Bought +16.67% shares Q2 2022	share	0.44%	620K	$20.23	$8.01	-60.41%	Bought +16.67% shares Q2 2022
Biotechnology KalVista Pharmaceuticals, Inc. Portfolio share: 0.41% Portfolio value: 580K Avg. open price: $18.99 Current price: $5.17 P/L: -72.78% Bought +33.33% shares Q1 2021	share	0.41%	580K	$18.99	$5.17	-72.78%	Bought +33.33% shares Q1 2021
Medical Devices iRhythm Technologies, Inc. Portfolio share: 0.35% Portfolio value: 501K Avg. open price: N/A Current price: $102.75 P/L: N/A N/A Q3 2021	share	0.35%	501K	N/A	$102.75	N/A	N/A Q3 2021
Biotechnology G1 Therapeutics, Inc. Portfolio share: 0.35% Portfolio value: 500K Avg. open price: $16.6 Current price: $6.17 P/L: -62.83% Bought +166.67% shares Q2 2019	share	0.35%	500K	$16.6	$6.17	-62.83%	Bought +166.67% shares Q2 2019
Medical Devices Silk Road Medical, Inc Portfolio share: 0.32% Portfolio value: 450K Avg. open price: $43.3 Current price: $53.65 P/L: +23.90% Bought +25.00% shares Q1 2022	share	0.32%	450K	$43.3	$53.65	+23.90%	Bought +25.00% shares Q1 2022
Biotechnology IVERIC bio, Inc. Portfolio share: 0.32% Portfolio value: 449K Avg. open price: $9.62 Current price: $21.89 P/L: +127.55% Bought +66.67% shares Q3 2022	share	0.32%	449K	$9.62	$21.89	+127.55%	Bought +66.67% shares Q3 2022
Biotechnology Nektar Therapeutics Portfolio share: 0.29% Portfolio value: 410K Avg. open price: $15.98 Current price: $2.97 P/L: -81.41% Bought +28.00% shares Q1 2022	share	0.29%	410K	$15.98	$2.97	-81.41%	Bought +28.00% shares Q1 2022
Biotechnology Soleno Therapeutics, Inc. Portfolio share: 0.29% Portfolio value: 409K Avg. open price: $0.88 Current price: $0.97 P/L: +9.84% Bought +319.31% shares Q1 2022	share	0.29%	409K	$0.88	$0.97	+9.84%	Bought +319.31% shares Q1 2022
Biotechnology Amicus Therapeutics, Inc. Portfolio share: 0.28% Portfolio value: 397K Avg. open price: $14.57 Current price: $12.37 P/L: -15.07% Bought +11.76% shares Q3 2018	share	0.28%	397K	$14.57	$12.37	-15.07%	Bought +11.76% shares Q3 2018
Biotechnology Kiniksa Pharmaceuticals, Ltd. Portfolio share: 0.27% Portfolio value: 385K Avg. open price: $13.93 Current price: $15.73 P/L: +12.92% Bought +50.00% shares Q3 2021	share	0.27%	385K	$13.93	$15.73	+12.92%	Bought +50.00% shares Q3 2021
Biotechnology Xenon Pharmaceuticals Inc. Portfolio share: 0.25% Portfolio value: 361K Avg. open price: N/A Current price: $38.83 P/L: N/A N/A Q2 2022	share	0.25%	361K	N/A	$38.83	N/A	N/A Q2 2022
Biotechnology Cullinan Oncology, Inc. Portfolio share: 0.23% Portfolio value: 322K Avg. open price: N/A Current price: $11.61 P/L: N/A Sold -44.33% shares Q3 2022	share	0.23%	322K	N/A	$11.61	N/A	Sold -44.33% shares Q3 2022
Biotechnology Protagonist Therapeutics, Inc. Portfolio share: 0.23% Portfolio value: 320K Avg. open price: $44.88 Current price: $7.8 P/L: -82.62% Bought +280.00% shares Q3 2021	share	0.23%	320K	$44.88	$7.8	-82.62%	Bought +280.00% shares Q3 2021
Biotechnology Xencor, Inc. Portfolio share: 0.23% Portfolio value: 320K Avg. open price: N/A Current price: $29.54 P/L: N/A N/A	share	0.23%	320K	N/A	$29.54	N/A	N/A
Biotechnology Sarepta Therapeutics, Inc. Portfolio share: 0.19% Portfolio value: 276K Avg. open price: N/A Current price: $122.96 P/L: N/A N/A Q3 2022	share	0.19%	276K	N/A	$122.96	N/A	N/A Q3 2022
Biotechnology BioCryst Pharmaceuticals, Inc. Portfolio share: 0.18% Portfolio value: 252K Avg. open price: N/A Current price: $11.58 P/L: N/A N/A Q2 2019	share	0.18%	252K	N/A	$11.58	N/A	N/A Q2 2019
Biotechnology Stoke Therapeutics, Inc. Portfolio share: 0.14% Portfolio value: 193K Avg. open price: N/A Current price: $7.16 P/L: N/A Sold -25.00% shares Q1 2021	share	0.14%	193K	N/A	$7.16	N/A	Sold -25.00% shares Q1 2021
Biotechnology InflaRx N.V. Portfolio share: 0.13% Portfolio value: 185K Avg. open price: N/A Current price: $2.5 P/L: N/A Sold -36.36% shares Q2 2020	share	0.13%	185K	N/A	$2.5	N/A	Sold -36.36% shares Q2 2020
Biotechnology Concert Pharmaceuticals, Inc. Portfolio share: 0.09% Portfolio value: 134K Avg. open price: N/A Current price: $4.76 P/L: N/A N/A Q1 2021	share	0.09%	134K	N/A	$4.76	N/A	N/A Q1 2021
Medical Devices Alphatec Holdings, Inc. Portfolio share: 0.06% Portfolio value: 87K Avg. open price: N/A Current price: $9.75 P/L: N/A N/A Q3 2022	share	0.06%	87K	N/A	$9.75	N/A	N/A Q3 2022
Agricultural Inputs Yield10 Bioscience, Inc. Portfolio share: 0.04% Portfolio value: 56K Avg. open price: $27.13 Current price: $2 P/L: -92.63% Sold -0.19% shares Q4 2021	share	0.04%	56K	$27.13	$2	-92.63%	Sold -0.19% shares Q4 2021
Packaged Foods Laird Superfood, Inc. Portfolio share: 0.04% Portfolio value: 51K Avg. open price: $14.67 Current price: $1.25 P/L: -91.48% Bought +55.56% shares Q1 2022	share	0.04%	51K	$14.67	$1.25	-91.48%	Bought +55.56% shares Q1 2022
Biotechnology Angion Biomedica Corp. Portfolio share: 0.04% Portfolio value: 50K Avg. open price: N/A Current price: $0.84 P/L: N/A Sold -10.27% shares Q3 2021	share	0.04%	50K	N/A	$0.84	N/A	Sold -10.27% shares Q3 2021
Biotechnology ContraFect Corporation Portfolio share: 0.02% Portfolio value: 34K Avg. open price: $6.9 Current price: $0.14 P/L: -97.93% Sold -21.78% shares Q4 2020	share	0.02%	34K	$6.9	$0.14	-97.93%	Sold -21.78% shares Q4 2020
Medical Devices Sientra, Inc. Portfolio share: 0.02% Portfolio value: 26K Avg. open price: N/A Current price: $0.27 P/L: N/A N/A Q2 2021	share	0.02%	26K	N/A	$0.27	N/A	N/A Q2 2021
Diagnostics & Research Aspira Women's Health Inc. Portfolio share: 0.02% Portfolio value: 22K Avg. open price: N/A Current price: $0.36 P/L: N/A Sold -27.72% shares Q3 2022	share	0.02%	22K	N/A	$0.36	N/A	Sold -27.72% shares Q3 2022
Biotechnology Zentalis Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $20.26 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$20.26	N/A	Sold -100.00% shares Q3 2022
Biotechnology Turning Point Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $76.01 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$76.01	N/A	Sold -100.00% shares Q3 2022

Showing TOP 62 BIRCHVIEW CAPITAL, LP's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of BIRCHVIEW CAPITAL, LP?

The biggest position of the BIRCHVIEW CAPITAL, LP is Bristol-Myers Squibb Company (BMY) with 36.43% portfolio share worth of 51.74M US dollars.

Top 5 BIRCHVIEW CAPITAL, LP's holdings represent 58.16% of the portfolio:

Bristol-Myers Squibb Company (BMY) – 36.43%
Aziyo Biologics, Inc. (AZYO) – 7.19%
Neurocrine Biosciences, Inc. (NBIX) – 6.37%
Prothena Corporation plc (PRTA) – 5.08%
QuidelOrtho Corporation (QDEL) – 3.09%

Who is the portfolio manager of BIRCHVIEW CAPITAL, LP?

The portfolio manager of the BIRCHVIEW CAPITAL, LP is .

What is the total asset value of the BIRCHVIEW CAPITAL, LP portfolio?

BIRCHVIEW CAPITAL, LP total asset value (portfolio value) is 142.01M US dollars.

Who is ?

is the portfolio manager of the BIRCHVIEW CAPITAL, LP.

What is (BIRCHVIEW CAPITAL, LP) fund performance?

BIRCHVIEW CAPITAL, LP's quarterly performance is +2.40%, annualy -12.30%. In the past 3 years, the value of 's portfolio has decreased by -70%. In the past 5 years, the value of the portfolio has decreased by -51%.

What is the BIRCHVIEW CAPITAL, LP CIK?

BIRCHVIEW CAPITAL, LP's Central Index Key is 0001618205 .

BIRCHVIEW CAPITAL, LP Holdings

BIRCHVIEW CAPITAL, LP portfolio value:

BIRCHVIEW CAPITAL, LP quarter portfolio value change:

BIRCHVIEW CAPITAL, LP 1 year portfolio value change:

BIRCHVIEW CAPITAL, LP 3 years portfolio value change:

BIRCHVIEW CAPITAL, LP 5 years portfolio value change: